Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis.

Biomarkers COVID-19 Critical care Histones Monocyte Monocyte distribution width Sepsis

Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
30 08 2022
Historique:
received: 24 06 2022
accepted: 19 08 2022
entrez: 30 8 2022
pubmed: 31 8 2022
medline: 3 9 2022
Statut: epublish

Résumé

Histone proteins are physiologically involved in DNA packaging and gene regulation but are extracellularly released by neutrophil/monocyte extracellular traps and mediate thrombo-inflammatory pathways, associated to the severity of many human pathologies, including bacterial/fungal sepsis and COVID-19. Prominent and promising laboratory features in classic and viral sepsis emphasize monocyte distribution width (MDW), due to its ability to distinguish and stratify patients at higher risk of critical conditions or death. No data are available on the roles of histones as MDW modifiers. Comparison of MDW index was undertaken by routine hematology analyzer on whole blood samples from patients with COVID-19 and Sepsis. The impact of histones on the MDW characteristics was assessed by the in vitro time-dependent treatment of healthy control whole blood with histones and histones plus lipopolysaccharide to simulate viral and classical sepsis, respectively. We demonstrated the breadth of early, persistent, and significant increase of MDW index in whole blood from healthy subject treated in vitro with histones, highlighting changes similar to those found in vivo in classic and viral sepsis patients. These findings are mechanistically associated with the histone-induced modifications of cell volume, cytoplasmic granularity and vacuolization, and nuclear structure alterations of the circulating monocyte population. Histones may contribute to the pronounced and persistent monocyte alterations observed in both acute classical and viral sepsis. Assessment of the biological impact of circulating histone released during COVID-19 and sepsis on these blood cells should be considered as key factor modulating both thrombosis and inflammatory processes, as well as the importance of neutralization of their cytotoxic and procoagulant activities by several commercially available drugs (e.g., heparins and heparinoids).

Identifiants

pubmed: 36042461
doi: 10.1186/s13054-022-04138-2
pii: 10.1186/s13054-022-04138-2
pmc: PMC9424804
doi:

Substances chimiques

Histones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

260

Informations de copyright

© 2022. The Author(s).

Références

J Intensive Care Med. 2022 Mar;37(3):319-326
pubmed: 33626964
Int J Lab Hematol. 2021 Aug;43(4):O161-O163
pubmed: 33554458
Thromb Res. 2015 Sep;136(3):542-7
pubmed: 26232351
J Leukoc Biol. 2021 Jan;109(1):13-22
pubmed: 33040384
Mol Cell Biochem. 2022 Feb;477(2):507-524
pubmed: 34796445
J Thromb Haemost. 2022 Jun;20(6):1485-1495
pubmed: 35313081
Crit Care. 2014 Sep 24;18(5):543
pubmed: 25260379
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028
pubmed: 32286245
J Clin Med. 2022 Mar 24;11(7):
pubmed: 35407410
Crit Care. 2020 Sep 4;24(1):549
pubmed: 32887652
Nat Med. 2009 Nov;15(11):1318-21
pubmed: 19855397
BMC Infect Dis. 2022 Jan 4;22(1):27
pubmed: 34983404
Cell Mol Immunol. 2022 May;19(5):577-587
pubmed: 35273357
Life Sci. 2020 Sep 15;257:118102
pubmed: 32687918
Haematologica. 2021 Sep 01;106(9):2493-2498
pubmed: 33832219
Sci Rep. 2021 Jun 16;11(1):12716
pubmed: 34135448
Clin Chem Lab Med. 2022 Feb 15;60(5):786-792
pubmed: 35166088
Clin Chem Lab Med. 2022 Jul 19;60(10):1506-1517
pubmed: 35852070
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994
pubmed: 33267662

Auteurs

Daniela Ligi (D)

Unit of Clinical Biochemistry, Section of Biochemistry and Biotechnology, Department of Biomolecular Sciences -DISB, University of Urbino Carlo Bo, Via A. Saffi, 2, 61029, Urbino, Italy.

Bruna Lo Sasso (B)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, BiND, University of Palermo, Via del Vespro, 90127, Palermo, Italy.

Rosaria Vincenza Giglio (RV)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, BiND, University of Palermo, Via del Vespro, 90127, Palermo, Italy.

Rosanna Maniscalco (R)

Unit of Clinical Biochemistry, Section of Biochemistry and Biotechnology, Department of Biomolecular Sciences -DISB, University of Urbino Carlo Bo, Via A. Saffi, 2, 61029, Urbino, Italy.

Chiara DellaFranca (C)

Unit of Clinical Biochemistry, Section of Biochemistry and Biotechnology, Department of Biomolecular Sciences -DISB, University of Urbino Carlo Bo, Via A. Saffi, 2, 61029, Urbino, Italy.

Luisa Agnello (L)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, BiND, University of Palermo, Via del Vespro, 90127, Palermo, Italy.

Marcello Ciaccio (M)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, BiND, University of Palermo, Via del Vespro, 90127, Palermo, Italy.
Department and U.O.C. Laboratory Medicine, University Hospital "Paolo Giaccone" of Palermo, Palermo, Italy.

Ferdinando Mannello (F)

Unit of Clinical Biochemistry, Section of Biochemistry and Biotechnology, Department of Biomolecular Sciences -DISB, University of Urbino Carlo Bo, Via A. Saffi, 2, 61029, Urbino, Italy. ferdinando.mannello@uniurb.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH